FrancophonIA/ELRC3.0 huggingface dataset:
English: *Comparison for daclatasvir was to a studies of daclatasvir 60 mg once daily with peginterferon alfa and ribavirin).
Danish: *Sammenligning for daclatasvir var til studier med daclatasvir 60 mg en gang dagligt sammen med peginterferon alfa cirkulerende metabolit af prodruget
English: The physician in charge of the diabetic care of the patient should be informed when DAA therapy is initiated.
Danish: Den læge, der er ansvarlig for patientens diabetesbehandling, bør informeres, når behandling med direkte virkende antivirale
English: Daklinza 30 mg and 60 mg film-coated tablets are available in packs of 28 tablets in non-perforated calendar blisters and perforated unit dose blisters.
Danish: Daklinza 30 mg og 60 mg filmovertrukne tabletter fås i pakninger med 28 tabletter i ikke-perforerede kalenderblisterpakninger og perforerede enkeltdosisblisterpakninger.
English: Warnings and precautions Talk to your doctor or pharmacist before taking Daklinza.
Danish: Kontakt lægen eller apoteketspersonalet, før du tager Daklinza.
English: EU/1/14/939/001 28 tablets (calendar pack)
Danish: MARKEDSFØRINGSTILLADELSESNUMMER (-NUMRE) EU/1/14/939/001 28 tabletter (kalenderpakning)
English: Daclatasvir was excreted into the milk of lactating rats with concentrations 1.7- to 2-fold maternal
Danish: Daclatasvir blev udskilt i mælken hos diegivende rotter ved koncentrationer 1,7 til 2 gange højere end de maternelle plasmakoncentrationer.
English: Administration of daclatasvir 60 mg tablet after a light meal resulted in no reduction in
Danish: Administration af daclatasvir 60 mg tablet efter et let måltid medførte ingen reduktion i daclatasvir-eksponering.
English: *PK parameters for daclatasvir when administered with peginterferon alfa and ribavirin in this study were similar to those observed in a study of HCV
Danish: *PK-parametre for daclatasvir, når det blev administreret med peginterferon alfa og ribavirin i dette studie var svarende til de PK-parametre, der blev
English: The safety and efficacy of Daklinza in children and adolescents aged <18 years have not yet been established.
Danish: Daklinzas sikkerhed og virkning hos børn og unge under 18 år er endnu ikke klarlagt.
English: EU/1/14/939/003 28 tablets (calendar pack)
Danish: MARKEDSFØRINGSTILLADELSESNUMMER (-NUMRE) EU/1/14/939/003 28 tabletter (kalenderpakning)
English: Expected: ↔ Daclatasvir
Danish: Forventes: ↔ Daclatasvir
English: What you need to know before you take Daklinza if you are allergic to daclatasvir or any of the other ingredients of this medicine (listed in section 6
Danish: Det skal du vide, før du begynder at tage Daklinza hvis du er allergisk over for daclatasvir eller et af de øvrige indholdsstoffer (angivet i afsnit 6) i hvis du tager et eller flere af følgende lægemidler (gennem munden eller på andre måder, der
English: Since Daklinza is used in combination with other agents, the contraindications and warnings for those
Danish: Eftersom Daklinza anvendes i kombination med andre midler, gælder kontraindikationer og advarsler
English: End of treatment HCV RNA undetectable
Danish: Afsluttet behandling HCV-RNA ikke detekterbart
English: nausea (feeling sick), diarrhoea, abdominal pain joint pain, aching or tender muscles, not caused by exercise When Daklinza is used together with sofosbuvir and ribavirin, the following side effects have been
Danish: ledsmerter, smertende eller ømme muskler, som ikke skyldes motion Når Daklinza anvendes sammen med sofosbuvir og ribavirin, er følgende bivirkninger blevet
English: * Mainly interferon-based therapy +/-NS3/4 PI. ** Cirrhosis was determined by liver biopsy, FibroScan >14.6 kPa, or FibroTest score ≥0.75 and aspartate aminotransferase (AST): platelet ratio index (APRI) >2.
Danish: * Hovedsageligt interferon-baseret behandling +/-NS3/4 PI. ** Cirrose blev konstateret ved leverbiopsi, FibroScan >14,6 kPa eller FibroTest score ≥0,75 og aspartataminotransferase (ASAT): blodplade-indeks (APRI) >2.
English: itching, dry skin, unusual hair loss or thinning, rash joint pain, aching or tender muscles, not caused by exercise, unusual weakness reduction in red blood cells (anaemia), reduction in white blood cells
Danish: kløe, tør hud, unormalt hårtab eller udtynding af håret, udslæt ledsmerter, smertende eller ømme muskler, som ikke skyldes motion, usædvanlig svaghedsfølelse nedsat mængde røde blodlegemer (anæmi), nedsat mængde hvide blodlegemer
English: Prior telaprevir or boceprevir failures
Danish: Tdiligere mislykket behandling med telaprevir eller boceprevir
English: Posology The recommended dose of Daklinza is 60 mg once daily, to be taken orally with or without meals.
Danish: Den anbefalede dosis af Daklinza er 60 mg en gang dagligt og indtages oralt med eller uden et måltid.
English: Follow guidelines above for haemoglobin 200 mg every other day Discontinue ribavirin
Danish: Ovenstående doseringsvejledning for hæmoglobin følges 200 mg hver anden dag Ribavirin seponeres
English: Nucleoside/nucleotide reverse transcriptase inhibitors (NRTIs)
Danish: Nukleosid/nukleotid revers transkriptasehæmmere (NRTI'er)
English: No clinically relevant effects on the pharmacokinetics of either medicinal product are expected when daclatasvir is coadministered with any of the following: PDE-5 inhibitors, medicinal products in the ACE inhibitor class (e.g. enalapril), medicinal products in the angiotensin II receptor antagonist class (e.g. losartan, irbesartan, olmesartan, candesartan, valsartan), disopyramide, propafenone, flecainide,
Danish: Der forventes ingen klinisk relevant indvirkning på farmakokinetikken af hverken det ene eller det andet lægemiddel ved administration af daclatasvir sammen med nogen af følgende: PDE-5-hæmmere, ACE-hæmmere (f.eks. enalapril), angiotensin II-receptorantagonister (f.eks. losartan, irbesartan, olmesartan, candesartan, valsartan), disopyramid, propafenon, flecainid, mexilitin, kinidin eller
English: Treatmentexperienced N=24
Danish: Behandlingserfare n N=24
English: Due to the long half-life of amiodarone, appropriate monitoring should also be carried out for patients who have discontinued amiodarone within the past few months and are to be initiated on Daklinza in
Danish: På grund af amiodarons lange halveringstid skal der desuden foretages passende overvågning af patienter, som inden for de seneste måneder har fået seponeret amiodaron og skal sættes i behandling med Daklinza i kombination med sofosbuvir.
English: For daclatasvirtreated patients with HCV RNA results at both follow-up Weeks 12 and 24, concordance of SVR12 and SVR24 was 97% for HCV genotype 1 and 100% for HCV genotype 4.
Danish: For daclatasvir-behandlede patienter med HCV-RNA-resultater ved både opfølgningsuge 12 og 24, var konkordansen mellem SVR12 og SVR24 97% for HCV-genotype 1 og 100% for
English: Expected: ↔ Daclatasvir ↔ NRTI
Danish: Forventes: ↔ Daclatasvir ↔ NRTI
English: Ribavirin Dosing Guidelines
Danish: Doseringsvejledning for ribavirin
English: Each film-coated tablet contains 30 mg or 60 mg daclatasvir
Danish: Hver filmovertrukket tablet indeholder 30 mg eller 60 mg daclatasvir
English: Among treatment-naïve patients with HCV RNA results at both follow-up Weeks 12 and 24, concordance between SVR12 and SVR24 was 99.5% independent of
Danish: Blandt behandlingsnaive patienter med HCV-RNA-resultater ved både opfølgningsuge 12 og 24 var konkordansen mellem SVR12 og SVR24 99,5% uanset behandlingsvarighed.
English: Treatmentexperienced* N=51
Danish: Behandlingserfaren* N=51
English: Diabetics may experience improved glucose control, potentially resulting in symptomatic hypoglycaemia, after initiating HCV DAA treatment.
Danish: Patienter med diabetes kan opleve forbedret blodsukkerkontrol efter påbegyndelse af HCV-behandling med direkte virkende antivirale lægemidler, hvilket potentielt kan resultere i symptomatisk hypoglykæmi.
English: Following multiple oral doses of daclatasvir 60 mg once daily in combination with peginterferon alfa and ribavirin in treatment-naïve patients with genotype 1 chronic HCV, the geometric mean (CV%) daclatasvir Cmax was 1534 (58) ng/ml, AUC0-24h was 14122 (70) ng•h/ml, and
Danish: Efter flere orale doser af daclatasvir 60 mg en gang dagligt i kombination med peginterferon alfa og ribavirin hos behandlingsnaive patienter med kronisk genotype 1-HCV var gennemsnitlig (CV%) Cmax for daclatasvir 1534 (58) ng/ml, AUC0-24h var 14122 (70) ng•h/ml, og Cmin var 232 (83) ng/ml.
English: Table 3: Treatment stopping rules in patients receiving Daklinza in combination with peginterferon alfa and ribavirin with inadequate on-treatment virologic response
Danish: Tabel 3: Regler for seponering hos patienter, der får Daklinza i kombination med peginterferon alfa og ribavirin med utilstrækkelig virologisk respons under
English: The SVR rate for patients treated for 8 weeks was lower with this treatment duration as summarized in Table 11.
Danish: SVR-raten for patienter, der blev behandlet i 8 uger, var lavere end for patienter, som fik 12 ugers behandling, hvilket er vist i
English: 600 mg daily 400 mg daily 200 mg daily Discontinue ribavirin
Danish: 600 mg dagligt 400 mg dagligt 200 mg dagligt Ribavirin seponeres
English: These active substances include but are not limited to phenytoin, carbamazepine, oxcarbazepine, phenobarbital, rifampicin, rifabutin, rifapentine, systemic dexamethasone, and the herbal product St John's wort (Hypericum perforatum).
Danish: Disse aktive stoffer omfatter, men er ikke begrænset til phenytoin, carbamazepin, oxcarbazepin, phenobarbital, rifampicin, rifabutin, rifapentin, systemisk dexamethason og naturlægemidlet perikon (Hypericum perforatum).
English: Daclatasvir inhibits both viral RNA replication
Danish: Daclatasvir hæmmer både viral RNA
English: Musculoskeletal and connective tissue disorders arthralgia, myalgia arthralgia, myalgia
Danish: artralgi, myalgi artralgi, myalgi
English: You should not breastfeed during
Danish: Du må ikke amme dit barn under behandling
English: Do not stop taking Daklinza unless your
Danish: Du må ikke stoppe med at tage Daklinza, medmindre din læge har bedt dig om det.
English: Due date
Danish: Langtidsdata
English: Daklinza 30 mg: the film-coated tablet is green, biconvex, pentagonal shape with "BMS" debossed on one side and "213" on the other side.
Danish: Daklinza 30 mg: den filmovertrukne tablet er grøn, bikonveks, pentagonal-formet og mærket med “BMS” på den ene side og “213” på den anden side.
English: 60 mg tablet orally followed by 100 μg [13C,15N]-daclatasvir intravenous dose, estimated volume of distribution at steady state was 47 l. In vitro studies indicate that daclatasvir is actively and passively transported into hepatocytes.
Danish: N]-daclatasvir som intravenøs dosis, var det estimerede distributionsvolumen ved steady-state (Vss) 47 l. In vitro-studier viser, at daclatasvir transporteres aktivt og passivt ind i hepatocytter.
English: Tell your doctor or pharmacist if you take any of the following medicines: amiodarone or digoxin, used to treat irregular heart beats atazanavir/ritonavir, atazanavir/cobicistat, elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate combination tablet, etravirine, nevirapine or efavirenz, used to treat HIV infection boceprevir or telaprevir, used to treat hepatitis C infection clarithromycin, telithromycin or erythromycin, used to treat bacterial infections warfarin and other similar medicines called vitamin K antagonists used to thin the blood.
Danish: Fortæl det til lægen eller apotekspersonalet, hvis du tager følgende medicin: amiodaron eller digoxin mod uregelmæssig hjerterytme atazanavir/ritonavir, atazanavir/cobicistat, kombinationstablet med elvitegravir/cobicistat/emtricitabin/tenofovirdisoproxilfumarat, etravirin, nevirapin eller efavirenz boceprevir eller telaprevir til behandling af hepatitis C-infektion clarithromycin, telithromycin eller erythromycin til behandling af bakterielle infektioner Warfarin og lignende lægemidler, såkaldte vitamin K-antagonister, der anvendes til fortynding af blodet.
English: One treatment-naïve patient was missing both post-treatment Weeks 12
Danish: En behandlingsnaiv patient manglede data for både uge 12 og 24 efter behandlingen.
English: Expected: ↔ Daclatasvir ↔ Enfuvirtide
Danish: Forventes: ↔ Daclatasvir ↔ Enfuvirtid
English: Ribavirin may be added based on clinical assessment of an individual patient.
Danish: Baseret på klinisk vurdering af den enkelte patient kan ribavirin
English: Mothers should be instructed not to breastfeed if they are taking Daklinza.
Danish: Mødre skal oplyses om, at de ikke må amme deres
English: Cases of severe bradycardia and heart block have been observed when Daklinza is used in combination with sofosbuvir and concomitant amiodarone and/or other drugs that lower heart rate (see
Danish: Der er iagttaget svær bradykardi og hjerteblok ved anvendelse af Daklinza i kombination med sofosbuvir samtidig med amiodaron og/eller andre hjertefrekvenssænkende lægemidler (se pkt.
English: 12 weeks therapy HCV Treatmentnaïve N=101
Danish: ALLY-2-studiet 12 ugers behandling HCV-behandlingsnaive N=101
English: dabigatran etexilate, used to to prevent blood clots ketoconazole, itraconazole, posaconazole or voriconazole, used to treat fungal infections verapamil, diltiazem, nifedipine or amlodipine, used to decrease blood pressure rosuvastatin, atorvastatin, fluvastatin, simvastatin, pitavastatin or pravastatin, used to lower blood cholesterol oral contraceptives
Danish: dabigatranetexilat til forebygelse af blodpropper ketoconazol, itraconazol, posaconazol eller voriconazol til behandling af svampeinfektioner verapamil, diltiazem, nifedipin eller amlodipin til behandling af forhøjet blodtryk rosuvastatin, atorvastatin, fluvastatin, simvastatin, pitavastatin eller pravastatin til behandling af for meget kolesterol i blodet p-piller
English: The overall median HCV RNA was 6.38 log10 IU/mL; the majority of patients (59%) had IL-28B rs12979860 non-CC genotypes.
Danish: Det samlede median-HCV-RNA var 6,38 log10 IE/ml, og størstedelen af patienterne (59%) havde IL-28B rs12979860 non-CC-genotyper.
English: The AUC associated with this dose in males is 19-fold the clinical
Danish: AUC associeret med denne dosis i hanner er 19 gange større end klinisk AUC-eksponering.
English: AI444043 was an open-label, single-arm study of daclatasvir with pegIFN/RBV in treatment-naïve adults with chronic HCV genotype 1 infection who were co-infected
Danish: AI444043 var et åbent, enkeltarmsstudie med daclatasvir sammen med pegIFN/RBV hos behandlingsnaive voksne med kronisk HCV-genotype 1-infektion,
English: Cmax: 0.95 (0.89, 1.02) Cmin: 1.17 (1.10, 1.24)
Danish: AUC: 1,10 (1,05; 1,15) Cmax: 0,95 (0,89; 1,02) Cmin: 1,17 (1,10; 1,24)
English: Table 15: Summary of noted newly emergent HCV NS5A substitutions on treatment or during follow-up in treated non-SVR12 subjects infected with HCV genotypes 1
Danish: Tabel 15: Oversigt over observerede nyopståede HCV-NS5A-substitutioner under behandling eller followup hos behandlede non-SVR12 forsøgspersoner med
English: PK trough levels for peginterferon alfa in patients who received peginterferon alfa, ribavirin, and daclatasvir were received peginterferon alfa, ribavirin,
Danish: Dalkoncentrationerne for PK for peginterferon alfa hos patienter, som fik peginterferon alfa, ribavirin og patienter, som fik peginterferon alfa,
English: The Cmax and AUC of total daclatasvir (free and protein-bound drug) were lower in subjects with hepatic impairment; however, hepatic impairment did not have a clinically significant effect on the free drug concentrations of daclatasvir
Danish: Cmax og AUC af total-daclatasvir (frit og proteinbundet lægemiddel) var lavere hos forsøgspersoner med nedsat leverfunktion.
English: Patients originally assigned to placebo and those in the daclatasvir group who did not achieve HCV RNA <LLOQ at Week 4 and undetectable at Week 10 continued pegIFN/RBV
Danish: Patienter, som oprindeligt blev placeret i behandlingsgruppen, der fik placebo og patienter i daclatasvir-gruppen, som ikke nåede HCV-RNA <LLOQ ved uge 4 og ikke-detekterbart HCV-RNA ved uge 10 fortsattte med pegIFN/RBV og gennemførte 48 ugers behandling.
English: Daklinza is given for 24 weeks, in combination with 24-48 weeks of peginterferon alfa and ribavirin: - If HCV RNA is undetectable at both treatment weeks 4 and 12, all 3 components of the regimen should be continued for a total duration of 24 weeks.
Danish: Daklinza administreres i 24 uger i kombination med 24-48 ugers behandling - Hvis HCV-RNA er ikke-detekterbart ved både behandlingsuge 4 og 12, bør alle 3 komponenter i - Hvis der opnås ikke-detekterbart HCV-RNA, men ikke både ved behandlingsuge 4 og 12, bør Daklinza seponeres ved uge 24, og peginterferon alfa og ribavirin bør fortsætte i i alt 48 uger.
English: Table 6: Treatment outcomes, daclatasvir in combination with sofosbuvir, HCV genotype 1 in
Danish: Tabel 6: Behandlingsresultater, daclatasvir i kombination med sofosbuvir, HCV-genotype 1 i
English: infection, the condition of your liver, and what other medicines you will take with Daklinza.
Danish: Behandlingsvarigheden vil afhænge af, om du tidligere er blevet behandlet for hepatitis C-infektion, din levers tilstand og, hvilken anden medicin du skal tage sammen med Daklinza.
English: ↔ Ethinylestradiol AUC: 1.01 (0.95, 1.07) Cmax: 1.11 (1.02, 1.20)
Danish: ↔ Ethinylestradiol AUC: 1,01 (0,95; 1,07)
English: migraine shortness of breath, cough, nasal congestion (blocked nose) hot flush dry skin, unusual hair loss or thinning, rash, itching diarrhoea, vomiting, abdominal pain, constipation, heartburn, excessive gas in the stomach or bowel dry mouth joint pain, aching or tender muscles, not caused by exercise
Danish: søvnbesvær, irritabilitet svimmelhed migræne åndenød, hoste, tilstoppet næse hedeture tør hud, unormalt hårtab eller udtynding af håret, udslæt, kløe diarre, opkastning, mavesmerter, forstoppelse, halsbrand, unormalt meget luft i maven eller tarmen mundtørhed ledsmerter, smertende eller ømme muskler, som ikke skyldes motion
English: Expected due to CYP3A4 induction by the anticonvulsant:
Danish: Forventes på grund af antimykobakterielle midlers induktion af CYP3A4:
English: If treatment interruption of components in the regimen is necessary because of adverse reactions, Daklinza must There are no virologic treatment stopping rules that apply to the combination of Daklinza with
Danish: Hvis det er nødvendigt at afbryde behandlingen med andre behandlingskomponenter på grund af bivirkninger, må Daklinza ikke gives
English: If you become pregnant, stop taking Daklinza and tell your doctor immediately.
Danish: Stop med at tage Daklinza og fortæl det straks til lægen, hvis du bliver
English: Patient demographics and baseline disease characteristics are summarised in Table 10.
Danish: Patienternes demografiske data og vigtigste sygdomskarakteristika ved baseline er vist i
English: * Mainly interferon-based therapy, but 7 patients received sofosbuvir + ribavirin and 2 patients received a ** Cirrhosis was determined by liver biopsy (METAVIR F4) for 14 patients, FibroScan >14.6 kPa for 11 patients or FibroTest score ≥0.75 and aspartate aminotransferase (AST): platelet ratio index (APRI) >2 for 7 patients.
Danish: ** Cirrose blev konstateret ved hjælp af leverbiopsi (METAVIR F4) hos 14 patienter, FibroScan >14,6 kPa hos 11 patienter eller FibroTest score ≥0,75 og aspartataminotransferase (ASAT): indeks for trombocytratio (APRI) >2 hos 7 patienter.
English: Table 7: Treatment outcomes, daclatasvir in combination with sofosbuvir for 24 weeks, treatment-naïve patients with HCV genotype 2 or 3 in Study AI444040
Danish: Tabel 7: Behandlingsresultater, daclatasvir i kombination med sofosbuvir i 24 uger, behandlingsnaive patienter med HCV-genotype 2 eller 3 i AI444040-studiet
English: If you have any questions about your medicines, please ask your doctor or
Danish: Er du i tvivl, så spørg lægen eller
English: Daklinza + sofosbuvir + ribavirin for 12 weeks Daklinza + sofosbuvir +/- ribavirin for 24 weeks
Danish: Daklinza + sofosbuvir + ribavirin i 12 uger Daklinza + sofosbuvir +/- ribavirin i 24 uger Daklinza + sofosbuvir +/- ribavirin i 24 uger (se pkt.
English: Skin and subcutaneous tissue disorders rash, alopecia, pruritus,
Danish: kvalme, diarre, abdominalsmerter udslæt, alopeci, pruritus,
English: The expiry date refers to the last day of that month.
Danish: Udløbsdatoen er den
English: Table 9: Treatment outcomes, daclatasvir in combination with sofosbuvir and ribavirin for 12 weeks, patients with cirrhosis or HCV recurrence after liver transplantation,
Danish: Tabel 9: Behandlingsresultater for daclatasvir i kombination med sofosbuvir og ribavirin i 12 uger hos patienter med cirrose eller recidiv af HCV efter levertransplantation.
English: The sofosbuvir resistance-associated substitution S282T emerged in only 1 non-SVR12 patient Emergent daclatasvir resistance-associated substitutions have been shown to persist for 3 years posttreatment and beyond for patients treated with daclatasvir-based regimens.
Danish: Den sofosbuvir-resistensassocierede substitution S282T opstod kun hos 1 non-SVR12 patient med
English: Daklinza 30 mg film-coated tablets Daklinza 60 mg film-coated tablets daclatasvir
Danish: Daklinza 30 mg filmovertrukne tabletter Daklinza 60 mg filmovertrukne tabletter daclatasvir
English: Light green biconvex pentagonal of dimensions 9.1 mm x 8.9 mm, debossed tablet with "BMS" on one
Danish: Lysegrøn bikonveks pentagonal tablet, der måler 9,1 mm x 8,9 mm og er mærket med “BMS” på den ene side og “215” på den anden side.
English: No dose adjustment of Daklinza is required for patients with any degree of renal impairment (see
Danish: Dosisjustering af Daklinza er ikke nødvendig hos patienter med hvilken som helst grad af
English: N.V. Bristol-Myers Squibb Belgium S.A.
Danish: Bristol-Myers Squibb Belgium S.A.
English: Non-responder (non-SVR12) Virologic failure Virologic breakthrough
Danish: Responderende (SVR12) Ikke-responderende (non
English: Daklinza + sofosbuvir +/- ribavirin for 24 weeks (see section 5.1)
Danish: Daklinza + sofosbuvir +/- ribavirin i 24 uger (se pkt.
English: All 3 HCV/HIV co
Danish: Samtidig infektion med HCV/hiv (ALLY-2)
English: Inhibition of OATP 1B1 and BCRP by
Danish: Daclatasvirs hæmning af OATP1B1 og
English: In patients who received daclatasvir
Danish: Hos patienter, som fik daclatasvir 60 mg
English: Green biconvex pentagonal of dimensions 7.2 mm x 7.0 mm, debossed tablet with "BMS" on one side
Danish: Daklinza 30 mg filmovertrukne tabletter Grøn bikonveks pentagonal tablet, der måler 7,2 mm x 7,0 mm og er mærket med “BMS” på den ene
English: * Patients who had missing data at follow-up Week 12 were considered responders if their next available ** Cirrhosis status was not reported for four patients in the daclatasvir + pegIFN/RBV group.
Danish: ** Cirrose-status blev ikke rapporteret for fire patienter i daclatasvir + pegIFN/RBV guppen.
English: Other None
Danish: Ingen
English: CARDIOVASCULAR AGENTS Antiarrhythmics
Danish: antibakterielle middels hæmning af
English: Respiratory, thoracic and mediastinal disorders dyspnoea, dyspnoea exertional, cough, nasal diarrhoea, vomiting, abdominal pain, gastrooesophageal reflux disease, constipation, dry mouth, flatulence nausea, diarrhoea, abdominal pain
Danish: Blod og lymfesystem insomni, irritabilitet insomni hovedpine svimmelhed, migræne svimmelhed, migræne dyspnø, funktionsdyspnø, hoste, tilstoppet næse diarre, opkastning, abdominalsmerter, gastroøsofageal reflukssygdom, obstipation, mundtørhed,
English: Discontinue Daklinza, peginterferon alfa and ribavirin Discontinue Daklinza, peginterferon alfa and ribavirin
Danish: Seponering af Daklinza, peginterferon alfa og ribavirin
English: Table 14: Treatment outcomes, daclatasvir in combination with peginterferon alfa and ribavirin (pegIFN/RBV), treatment-naïve patients with HCV genotype 4
Danish: Tabel 14: Behandlingsresultater, daclatasvir i kombination med peginterferon alfa og ribavirin (pegIFN/RBV), behandlingsnaive patienter med HCV-genotype 4 Studie AI444010 daclatasvir + pegIFN/RBV N=12
English: Elimination
Danish: Fordeling
English: One patient with HCV genotype 2 infection was missing both post
Danish: En patient med HCV-genotype 2-infektion manglede data for både uge 12 og 24 efter behandlingen.